Marta Cortes-Canteli
Overview
Explore the profile of Marta Cortes-Canteli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1217
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Toribio-Fernandez R, Ceron C, Tristao-Pereira C, Fernandez-Nueda I, Perez-Castillo A, Fernandez-Ferro J, et al.
Br J Pharmacol
. 2023 Jan;
181(6):760-776.
PMID: 36633908
Alzheimer's disease (AD) and cardiovascular disease (CVD) are strongly associated. Both are multifactorial disorders with long asymptomatic phases and similar risk factors. Indeed, CVD signatures such as cerebral microbleeds, micro-infarcts,...
12.
Clemente-Moragon A, Oliver E, Calle D, Cusso L, Gomez M, Pradillo J, et al.
Br J Pharmacol
. 2022 Oct;
180(4):459-478.
PMID: 36181002
Background And Purpose: Reperfusion therapy is the standard of care for ischaemic stroke; however, there is a need to identify new therapeutic targets able to ameliorate cerebral damage. Neutrophil β...
13.
Alarcon-Gil J, Sierra-Magro A, Morales-Garcia J, Sanz-SanCristobal M, Alonso-Gil S, Cortes-Canteli M, et al.
Cells
. 2022 Jul;
11(15).
PMID: 35892594
Parkinson's disease (PD) is the second most prevalent neurodegenerative disease after Alzheimer's disease. The principal pathological feature of PD is the progressive loss of dopaminergic neurons in the ventral midbrain....
14.
Cortes-Canteli M, Gispert J, Salvado G, Toribio-Fernandez R, Tristao-Pereira C, Falcon C, et al.
J Am Coll Cardiol
. 2021 Feb;
77(7):888-898.
PMID: 33602472
Background: Atherosclerosis has been linked to cognitive decline in late life; however, the impact of cardiovascular risk factors (CVRFs) and subclinical atherosclerosis on brain metabolism at earlier stages remains unexplored....
15.
Cortes-Canteli M, Iadecola C
J Am Coll Cardiol
. 2020 Mar;
75(8):942-951.
PMID: 32130930
Alzheimer's disease, the leading cause of dementia in the elderly, is a neurodegenerative condition characterized by accumulation of amyloid plaques and neurofibrillary tangles in the brain. However, age-related vascular changes...
16.
Cortes-Canteli M, Kruyer A, Fernandez-Nueda I, Marcos-Diaz A, Ceron C, Richards A, et al.
J Am Coll Cardiol
. 2019 Oct;
74(15):1910-1923.
PMID: 31601371
Background: Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder with important vascular and hemostatic alterations that should be taken into account during diagnosis and treatment. Objectives: This study evaluates whether...
17.
Cruz Hernandez J, Bracko O, Kersbergen C, Muse V, Haft-Javaherian M, Berg M, et al.
Nat Neurosci
. 2019 Feb;
22(3):413-420.
PMID: 30742116
Cerebral blood flow (CBF) reductions in Alzheimer's disease patients and related mouse models have been recognized for decades, but the underlying mechanisms and resulting consequences for Alzheimer's disease pathogenesis remain...
18.
Hernandez-Encinas E, Aguilar-Morante D, Cortes-Canteli M, Morales-Garcia J, Gine E, Santos A, et al.
J Neuroinflammation
. 2015 Jan;
12:14.
PMID: 25617152
Background: The CCAAT/enhancer-binding protein β (C/EBPβ) is a transcription factor, which was first identified as a regulator of differentiation and inflammatory processes mainly in adipose tissue and liver; however, its...
19.
Cortes-Canteli M, Mattei L, Richards A, Norris E, Strickland S
Neurobiol Aging
. 2014 Dec;
36(2):608-17.
PMID: 25475538
Alzheimer's disease (AD) is the most common form of dementia and has no effective treatment. Besides the well-known pathologic characteristics, this disease also has a vascular component, and substantial evidence...
20.
Cortes-Canteli M, Zamolodchikov D, Ahn H, Strickland S, Norris E
J Alzheimers Dis
. 2012 Aug;
32(3):599-608.
PMID: 22869464
Alzheimer's disease (AD) is characterized by amyloid-β (Aβ) plaques, tau tangles, brain atrophy, and vascular pathology. Vascular defects include cerebrovascular dysfunction, decreased cerebral blood flow, and blood brain barrier (BBB)...